These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34905461)

  • 1. Differences in Outcomes between Heart Failure Phenotypes in Patients with Coexistent Chronic Obstructive Pulmonary Disease: A Cohort Study.
    Gulea C; Zakeri R; Quint JK
    Ann Am Thorac Soc; 2022 Jun; 19(6):971-980. PubMed ID: 34905461
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
    Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
    Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical characteristics and outcomes of heart failure patient with chronic obstructive pulmonary disease from the Japanese community-based registry.
    Takabayashi K; Terasaki Y; Okuda M; Nakajima O; Koito H; Kitamura T; Kitaguchi S; Nohara R
    Heart Vessels; 2021 Feb; 36(2):223-234. PubMed ID: 32770265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise ventilatory inefficiency in heart failure and chronic obstructive pulmonary disease.
    Smith JR; Van Iterson EH; Johnson BD; Borlaug BA; Olson TP
    Int J Cardiol; 2019 Jan; 274():232-236. PubMed ID: 30201380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
    Yang M; Kondo T; Adamson C; Butt JH; Abraham WT; Desai AS; Jering KS; Køber L; Kosiborod MN; Packer M; Rouleau JL; Solomon SD; Vaduganathan M; Zile MR; Jhund PS; McMurray JJV
    Eur J Heart Fail; 2023 Sep; 25(9):1606-1618. PubMed ID: 37401511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.
    Fitzsimons S; Yeo TJ; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton R; Lam CSP; Richards AM; Doughty RN
    ESC Heart Fail; 2021 Dec; 8(6):4572-4583. PubMed ID: 34592056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry.
    Chioncel O; Benson L; Crespo-Leiro MG; Anker SD; Coats AJS; Filippatos G; McDonagh T; Margineanu C; Mebazaa A; Metra M; Piepoli MF; Adamo M; Rosano GMC; Ruschitzka F; Savarese G; Seferovic P; Volterrani M; Ferrari R; Maggioni AP; Lund LH
    Eur J Prev Cardiol; 2023 Sep; 30(13):1346-1358. PubMed ID: 37172316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.
    Ather S; Chan W; Bozkurt B; Aguilar D; Ramasubbu K; Zachariah AA; Wehrens XH; Deswal A
    J Am Coll Cardiol; 2012 Mar; 59(11):998-1005. PubMed ID: 22402071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
    Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN
    Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.